I Prostanoid Receptor Activation Attenuates Pressure Overload-induced Cardiac Hypertrophy by Enhancing Glucose Oxidation
Overview
Overview
Journal
Signal Transduct Target Ther
Specialties
Cell Biology
Pharmacology
Pharmacology
Date
2023 Sep 5
PMID
37669930
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Lu Y, Wang D
. Non-coding RNA in Ischemic and Non-ischemic Cardiomyopathy. Curr Cardiol Rep. 2018; 20(11):115.
DOI: 10.1007/s11886-018-1055-y.
View
2.
Lopaschuk G, Karwi Q, Tian R, Wende A, Abel E
. Cardiac Energy Metabolism in Heart Failure. Circ Res. 2021; 128(10):1487-1513.
PMC: 8136750.
DOI: 10.1161/CIRCRESAHA.121.318241.
View
3.
Ricciotti E, FitzGerald G
. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31(5):986-1000.
PMC: 3081099.
DOI: 10.1161/ATVBAHA.110.207449.
View
4.
Yan S, Zhang Q, Zhong X, Tang J, Wang Y, Yu J
. I prostanoid receptor-mediated inflammatory pathway promotes hepatic gluconeogenesis through activation of PKA and inhibition of AKT. Diabetes. 2014; 63(9):2911-23.
DOI: 10.2337/db13-1893.
View
5.
Fan J, Shan C, Kang H, Elf S, Xie J, Tucker M
. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Mol Cell. 2014; 53(4):534-48.
PMC: 3943932.
DOI: 10.1016/j.molcel.2013.12.026.
View